CD4 and COVID-19: The majority of SARS-CoV-2-specific CD4+ T cells from COVID-19 patients show a clear IFN-γ, tumor necrosis factor (TNF) and IL-2 protein signature characteristic of canonical Th1 cells (30, 31, 39).